nonimmun
kitten
passiv
immun
felin
serum
contain
hightit
antibodi
reactiv
felin
infecti
periton
viru
fipv
develop
rapid
diseas
fipv
challeng
kitten
pretreat
fipv
antibodyneg
serum
antibodysensit
fipv
challeng
kitten
develop
earlier
clinic
sign
includ
pyrexia
icteru
thrombocytopenia
die
rapidli
nonsensit
flpvchalleng
kitten
mean
surviv
time
sensit
kitten
significantli
p
reduc
compar
nonsensit
kitten
mean
sem
day
vs
day
respect
lesion
induc
includ
fibrin
periton
dissemin
pyogranulomat
inflamm
necrot
phlebiti
periphleb
fipv
antigen
immunoglobulin
g
complement
fibrinogen
demonstr
lesion
immunofluoresc
microscopi
pathogenesi
dengu
hemorrhag
fever
dhf
person
bear
strike
resembl
fip
experiment
kitten
fip
dhf
nonneutr
antibodi
may
promot
acut
diseas
enhanc
viru
infect
mononuclear
phagocyt
format
immun
complex
activ
complement
secondari
vascular
disturb
key
word
felin
infecti
periton
fip
dengu
hemorrhag
fever
dhf
immunepatholog
immunofluoresc
passiv
immun
role
de
anticorp
dan
laggrav
de
la
piritonit
infectieux
felin
avec
une
fiivr
himorragiqu
la
dengu
chaton
passiv
immunis
par
du
serum
felin
conten
un
titr
elev
en
anticorp
reagiss
avec
le
viru
de
la
peritonit
infectieux
felin
ont
developp
une
maladi
plu
rapid
apr
inject
viral
experimental
que
ceux
ayant
rec
u
un
serum
depourvu
de
ce
anticorp
le
chaton
sensibili
par
le
anticorp
et
infect
par
la
viru
pif
developp
le
plu
rapid
notam
de
la
fivr
ictr
et
une
thrombocytopeni
et
meurent
plu
vite
que
le
nonsensibilis
la
dure
de
survi
moyenn
chez
le
chaton
sensilis
est
reduit
significativ
p
par
rapport
cell
de
non
sensibilis
mean
sem
vs
jour
respectiv
le
lesion
observe
comprenn
une
peritonit
fibrineus
une
inflamm
pyogranulomateus
dissenime
et
une
phlebit
et
periphlebit
necrosant
lantign
du
fipv
le
immunologlobulin
g
le
fragment
du
complement
et
le
fibrinogen
ont
ere
revel
dan
le
lesion
par
immunofluoresc
la
pathogenei
de
la
fievr
hemorragiqu
dengu
dhf
chez
lhomm
montr
une
ressembl
etonnant
avec
cell
de
la
pif
experimental
chez
le
chaton
dan
le
deux
ca
le
anticorp
non
neuralis
peuvent
permettr
une
maladi
plu
fort
par
laugment
de
linfect
par
le
viru
de
cellul
phagocytair
monoucle
par
activ
du
complement
et
par
de
pertub
vasculair
secondair
motsclef
peritonit
infectieus
felin
la
fievr
hemorragiqu
dengu
immunopathologi
immunofluoresc
immunit
passiv
felin
infecti
periton
fip
contagi
highli
fatal
coronaviru
diseas
domest
exot
cat
cat
natur
expos
fip
viru
fipv
develop
antibodi
titer
without
show
clinic
sign
small
number
infect
cat
eventu
week
year
later
develop
fatal
system
diseas
character
fibrin
periton
pleuriti
dissemin
granulomata
reason
viru
dissemin
previous
expos
cat
unknown
lesion
fip
character
histolog
gener
vascul
perivascul
fibronecrot
pyogranulomat
imflamm
seros
membran
parenchym
organ
mesotheli
hyperplasia
lesion
believ
result
immunologicallymedi
tissu
reaction
respons
system
viru
infect
spontan
fip
case
frequent
demonstr
mark
hyperproteinemia
greater
hypergammaglobulinemia
polyclon
gammopathi
markedli
elev
antifipv
serum
antibodi
titer
circul
immun
complex
renal
glomerular
deposit
immunoglobulin
ig
g
complement
detect
cat
spontan
experiment
induc
fip
previou
experi
laboratori
demonstr
mark
acceler
diseas
clinic
normal
fipv
antibodyposit
kitten
challeng
fipv
mani
kitten
die
develop
acut
dissemin
intravascular
coagul
dic
sever
system
vascul
fip
viral
antigen
immunoglobulin
g
demonstr
hepat
lesion
addit
studi
demonstr
healthi
nonvirem
seroposit
kitten
develop
viremia
vascular
lesion
earlier
die
rapidli
fipv
challeng
seroneg
kitten
studi
show
fipv
persist
circul
mononuclear
cell
infect
kitten
despit
high
level
antifipv
antibodi
investig
recent
report
enhanc
diseas
fipvchalleng
kitten
possess
natur
acquir
passiv
administ
antibodi
fipv
studi
demonstr
fipv
virusbound
igg
complement
within
macrophag
lesion
hypocomplementemia
occurr
nonneutr
serum
antibodi
infect
cat
immunopatholog
featur
fip
cat
propos
pathogenesi
dengu
hemorrhag
fever
dhf
person
show
strike
similar
major
case
dhf
occur
secondari
infect
patient
preexist
serum
antibodi
dengu
virus
postul
upon
reinfect
heterolog
serotyp
dengu
viru
patient
dhf
rapidli
develop
high
titer
crossreact
nonneutr
antibodi
format
larg
amount
viru
antibodi
complex
may
lead
activ
complement
hemorrhag
shock
syndrom
dhf
fip
viru
replic
persist
mononuclear
phagocyt
presenc
nonneutr
antibodi
circul
immun
complex
decreas
serum
complement
level
may
occur
viru
antivir
antibodi
complement
compon
demonstr
within
blood
vessel
lesion
dic
may
develop
certain
case
although
previou
experi
demonstr
enhanc
diseas
fipv
antibodi
horzinek
c
palhogenesi
felin
infecti
periton
seminar
pre
ent
al
cornel
universili
llhaca
new
york
june
posit
cat
reexpos
fipv
still
necessari
show
phenomenon
mediat
serum
factor
ie
antibodi
react
fipv
purpos
present
studi
therefor
twofold
demonstr
antibodymedi
enhanc
diseas
experiment
fip
compar
find
immunopatholog
featur
dhf
kitten
divid
three
experiment
group
follow
one
group
three
kitten
receiv
cat
serum
contain
high
titer
antifipv
antibodi
prior
fipv
infect
antibodysensit
group
second
group
four
kitten
receiv
cat
serum
contain
antifipv
antibodi
prior
infect
nonsensit
group
third
group
two
kitten
receiv
fipv
antibodyposit
serum
challeng
fipv
serum
control
infect
control
kitten
monitor
daili
fever
clinic
sign
infect
kitten
bled
hr
prior
infect
day
interv
infect
complet
blood
count
cbc
platelet
count
bilirubin
serum
enzym
fipv
serum
antibodi
titer
determin
kitten
prior
infect
postinocul
day
pid
postmortem
necropsi
examin
perform
infect
control
kitten
tissu
process
histopatholog
immunofluoresc
microscopi
anim
twelveweekold
specificpathogenfre
spf
kitten
obtain
commerci
breeder
liberti
laboratori
liberti
corner
new
jersey
kitten
hous
standard
horsfal
isol
cage
maintain
cornel
laboratori
anim
isol
facil
infect
cat
noninfect
control
hous
separ
isol
unit
viru
strain
fipv
provid
dr
n
pedersen
univers
california
davi
pass
three
time
spf
cat
laboratori
store
c
ml
aliquot
liver
homogen
previou
titrat
determin
ml
yield
approxim
cat
infecti
dose
cultur
liver
homogen
bacteria
mycoplasma
felin
leukemia
viru
cytopath
felin
virus
neg
prepar
oimmun
non
immun
serum
healthi
kitten
serum
antibodi
titer
greater
serv
immun
serum
donor
anim
spf
kitten
seroconvert
natur
exposur
fipvshed
contact
cat
remain
asymptomat
spf
kitten
whose
serum
neg
fipv
antibodi
serv
nonimmun
donor
kitten
bled
week
interv
blood
collect
jugular
venepunctur
steril
glass
tube
without
anticoagul
centrifug
serum
withdrawn
dispos
pipett
store
c
steril
glass
vial
use
passiv
transer
serum
experiment
infect
mild
sedat
kitten
ketamin
hydrochlorid
vetelar
park
davi
co
detroit
michigan
mgkg
given
im
atropin
sulfat
sussex
drug
co
edison
new
jersey
mgkg
given
im
extern
jugular
vein
catheter
needl
butterfli
infus
set
abbott
hospit
inc
north
chicago
illinoi
serum
administ
slow
intraven
inject
given
dosag
mlkg
per
cat
six
hr
administr
serum
experiment
kitten
inocul
intraperiton
ml
fipvinfect
liver
homogen
approxim
control
kitten
inocul
similarli
liver
homogen
fipvneg
cat
hematolog
evalu
cbc
platelet
count
serolog
test
ml
blood
collect
vacuumevacu
tube
contain
ml
edta
anticoagul
vacutain
tube
becton
dickinson
rutherford
new
jersey
total
erythrocyt
leukocyt
count
perform
electron
cell
counter
coulter
counter
model
zf
coulter
electron
hiahleah
florida
pack
cell
volum
determin
microhematocrit
method
differenti
leukocyt
count
made
wright
stain
blood
smear
platelet
count
perform
direct
count
method
commerci
avail
blood
dilut
pipett
unopett
becton
dickinson
co
columbu
nebraska
phase
contrast
microscopi
total
bilirubin
determin
semiautom
method
coulter
chemistri
coulter
electron
hiahleah
florida
direct
indirect
bilirubin
determin
made
unmodifi
evelynmalloy
procedur
serum
activ
alanin
aminotransferas
alt
determin
commerci
avail
kinet
photometr
techniqu
fisher
diagnost
fair
lawn
new
jersey
serum
activ
aspart
aminotransferas
ast
determin
colorimetr
prepar
substrat
tran
ac
test
kit
gener
diagnost
morri
plain
new
jersey
fipv
serum
antibodi
test
perform
heterolog
indirect
fluoresc
antibodi
test
use
crossreact
transmiss
gastroenter
viru
pig
antigen
patholog
immunopatholog
studi
complet
postmortem
examin
made
infect
kitten
control
cat
necropsi
pid
repres
section
organ
fix
neutral
buffer
formalin
embed
paraffin
section
tm
stain
hematoxylin
eosin
section
liver
lung
mesenter
lymph
node
omentum
spleen
frozen
immers
liquid
nitrogen
store
cryostatmicrotom
section
process
immunofluoresc
microscopi
indirect
fluoresc
antibodi
techniqu
detect
fip
viral
antigen
perform
essenti
describ
pedersen
except
fluorescein
isothiocyan
fitc
conjug
staph
protein
pharmacia
fine
chemic
piscataway
new
jersey
replac
fitcconjug
rabbit
anticat
immunoglobulin
g
igg
former
bind
specif
fc
region
igg
number
speci
demonstr
igg
complement
fibrinogen
acetonefix
section
sampl
overlaid
fitcconjug
staph
protein
fitcconjug
goat
antidog
lot
cappel
laboratori
inc
cochranvil
pennsylvania
fitcconjug
goat
antihuman
fibrinogen
lot
mile
laboratori
inc
elkart
indiana
respect
previou
pilot
studi
laboratori
demonstr
immunofluoresc
microscopi
crossreact
canin
felin
human
felin
fibrinogen
companion
sampl
stain
proteina
wash
buffer
ph
prior
stain
incub
min
slide
wash
three
time
phosphatebuff
salin
solut
pbss
ph
counterstain
min
pbss
contain
dilut
evan
blue
stain
slide
examin
epifluoresc
ultraviolet
microscop
dialux
microscop
wetzler
ernst
leitz
ltd
midland
ontario
canada
statist
analys
differ
surviv
time
antibodysensit
nonsensit
kitten
test
signific
mannwhitney
test
nonparametr
method
mean
differ
two
group
platelet
count
test
signific
student
test
valu
accept
signific
p
antibodysensit
kitten
develop
initi
rise
bodi
temperatur
pid
fig
temperatur
remain
elev
day
drop
subnorm
temperatur
less
within
hr
preced
death
two
nonsensit
kitten
develop
transient
temperatur
elev
c
pid
persist
temperatur
nonsensit
kitten
first
occur
persist
fever
accompani
anemia
icteru
dehydr
depress
weight
loss
pendul
abdomen
icteru
first
occur
pid
sensit
kitten
pid
nonsensit
kitten
infect
kitten
develop
enlarg
mesenter
lymph
node
mild
moder
ascit
mortal
rate
group
infect
kitten
mean
surviv
time
significantli
p
decreas
sensit
kitten
compar
nonsensit
kitten
mean
surviv
time
sem
rang
day
sensit
kitten
vs
rang
day
nonsensit
kitten
control
kitten
develop
fever
clinic
symptom
sequenti
chang
cbc
platelet
count
total
bilirubin
serum
enzym
infect
kitten
present
tabl
infect
kitten
develop
progress
normochrom
normocyt
anemia
moder
poikilocytosi
total
leukocyt
count
decreas
preinocul
level
absolut
rel
decreas
number
lymphocyt
reduct
platelet
number
first
occur
pid
sensit
kitten
pid
nonsensit
kitten
signific
p
differ
mean
platelet
count
sensit
nonsensit
kitten
occur
pid
sensit
kitten
gener
develop
sever
thrombocytopenia
demonstr
platelet
count
less
cellsmm
pid
elev
serum
level
bilirubin
increas
activ
alt
ast
first
detect
pid
group
kitten
tabl
hyperbilirubinemia
pronounc
sensit
kitten
occasion
exceed
mgdl
serum
activ
ast
infect
kitten
increas
fourtofivefold
pid
alt
activ
rose
twotothreefold
pid
kitten
given
fipv
immun
serum
intraven
develop
passiv
antibodi
titer
within
hr
fig
antibodi
titer
viruschalleng
passiv
immun
kitten
decreas
pid
respect
kitten
given
nonimmun
serum
challeng
viru
remain
seroneg
pid
kitten
develop
elev
fipv
antibodi
titer
follow
week
demonstr
maxim
titer
pid
nonchalleng
control
kitten
given
fipv
immun
serum
demonstr
mean
passiv
antibodi
titer
pid
pid
less
pid
characterist
gross
microscop
lesion
experiment
fip
detail
previou
report
summar
gross
lesion
usual
appear
dissemin
mm
greywhit
yellow
foci
pariet
viscer
peritoneum
pleura
pericardium
omentum
mesenteri
liver
spleen
kidney
pancrea
diaphragm
abdomin
thorac
lymph
node
petechi
hemorrhag
fibrin
commonli
associ
loci
abdomin
sternal
lymph
node
enlarg
clear
yellow
viscou
periton
fluid
contain
fibrin
strand
develop
excess
ml
cat
fig
microscop
lesion
consist
dissemin
foci
necrosi
pyogranulomat
inflamm
frequent
orient
around
small
vein
venul
seros
membran
omentum
fig
liver
fig
spleen
intestin
lung
kidney
eye
brain
foci
character
perivascular
vascular
infiltr
macrophag
neutrophil
lymphocyt
fibrin
necrot
debri
affect
vein
frequent
demonstr
degener
necrosi
cell
media
adventitia
perivascular
edema
fibrin
thrombi
occasion
present
especi
pulmonari
hepat
vein
reticuloendotheli
hyperplasia
lymphoid
hyperplasia
deplet
necrosi
occur
lymphoreticular
organ
spleen
thymu
lymph
node
mark
erythrophagia
macrophag
frequent
observ
sinus
spleen
lymph
node
mesotheli
hyperplasia
commonli
present
seros
membran
lesion
observ
tissu
control
kitten
serial
section
lesion
spleen
liver
lung
omentum
mesenter
lymph
node
stain
posit
fip
viral
antigen
igg
fibrinogen
lesion
posit
pid
specif
fluoresc
fip
viral
antigen
igg
observ
granular
diffus
stain
cytoplasm
within
mononuclear
inflammatori
cell
fig
b
c
antifibrinogen
immunofluoresc
observ
predominantli
extracellular
deposit
strand
fiber
invest
cell
within
lesion
fig
dens
deposit
within
vascular
lumen
wash
slide
acid
glycin
buffer
prior
stain
igg
result
reduct
specif
antiigg
fluoresc
specif
fluoresc
fipv
igg
fibrinogen
observ
tissu
control
cat
nonimmun
kitten
passiv
immun
serum
contain
high
titer
antibodi
reactiv
fipv
develop
enhanc
diseas
later
challeng
viru
compar
kitten
pretreat
nonimmun
serum
fipv
antibodysensit
kitten
develop
clinic
sign
earlier
die
rapidli
infect
nonsensit
kitten
show
clinic
sign
die
fip
activ
antibodi
respons
demonstr
find
confirm
earlier
observ
made
pedersen
boyl
examin
lesion
infect
kitten
show
widespread
necrosi
vascular
inflamm
evid
mark
chang
vascular
permeabl
ie
perivascular
edema
effus
transud
fluid
bodi
caviti
sever
inflamm
vein
multipl
organ
suggest
system
arthustyp
reaction
latter
local
inflammatori
lesion
venul
character
granulocyt
infiltr
edema
necrosi
hemorrhag
produc
experiment
local
inject
antigen
previous
immun
anim
complement
activ
secondari
local
immun
complex
format
within
venul
lead
inflamm
chang
vascular
permeabl
find
fip
viral
antigen
igg
lesion
fipvinfect
kitten
studi
previou
investig
suggest
complement
activ
secondari
antigenantibodi
reaction
may
inde
central
mechan
pathogenesi
fip
complement
activ
fip
may
result
intravascular
perivascular
deposit
immun
complex
possibl
cytotox
complementfix
antibodi
direct
virusinfect
cell
antibodymedi
immun
complexmedi
immunopatholog
reaction
around
small
blood
vessel
may
result
endotheli
injuri
platelet
aggreg
microthrombi
format
dissemin
intravascular
coagul
dic
sever
case
dic
induc
fip
antibodyposit
kitten
experiment
infect
fipv
fipvinfect
kitten
present
studi
develop
sever
phlebiti
occasion
thrombosi
mark
deposit
fibrinogen
within
vein
lesion
interest
observ
earlier
sever
thrombocytopenia
antibodysensit
vs
nonsensit
kitten
find
may
reflect
earli
immunolog
reaction
vein
perhap
two
consequ
intravascular
complement
activ
immun
complex
vascul
platelet
clump
site
endotheli
injuri
complementmedi
platelet
aggreg
altern
may
acceler
antibodymedi
lysi
platelet
sensit
kitten
kitten
given
fipvimmun
serum
develop
fever
within
hr
viru
infect
contrast
similar
temperatur
observ
kitten
given
nonimmun
serum
pid
two
nonsensit
kitten
develop
mild
transient
fever
pid
onset
clinic
sign
nonsensit
kitten
coincid
close
seroconvers
appear
second
temperatur
spike
latter
may
repres
system
immunopatholog
diseas
eg
immun
complex
hypersensit
perhap
late
secondari
viremia
wherea
mild
transient
temperatur
rise
pid
two
nonsensit
kitten
suggest
primari
viremia
earlier
persist
fever
seroposit
kitten
contrast
may
reflect
enhanc
antibodymedi
viral
infect
result
rapid
viremia
immunopatholog
diseas
inde
previou
studi
laboratori
shown
earlier
cell
infect
viremia
vascul
fipvchalleng
seroposit
kitten
compar
seroneg
kitten
suggest
fipv
antibodi
may
involv
immunopatholog
diseas
ie
immun
complex
diseas
complementmedi
cytotox
also
vivo
antibodymedi
enhanc
viru
infect
macrophag
latter
phenomenon
report
vitro
vivo
studi
dengu
viru
infect
monkey
rapid
declin
passiv
antibodi
titer
fipvchalleng
kitten
compar
unchalleng
control
present
studi
suggest
fipv
antibodi
activ
consum
cours
diseas
addit
spontan
degrad
former
could
repres
bind
free
antibodi
viru
immun
complex
prior
activ
primari
humor
immun
respons
complex
may
circul
free
serum
deposit
blood
vessel
phagocyt
mononuclear
phagocyt
blood
around
blood
vessel
wall
antibodymedi
enhanc
diseas
demonstr
laboratori
kitten
infect
fipv
resembl
certain
immunopatholog
featur
dengu
hemorrhag
fever
dhf
person
patient
preinfect
heterotyp
immun
one
four
known
serotyp
dengu
viru
occasion
develop
sever
shock
syndrom
infect
differ
serotyp
syndrom
character
fever
mark
chang
vascular
permeabl
hypovolem
shock
thrombocytopenia
hemorrhag
diathesi
sever
theori
propos
explain
occurr
dhf
one
view
complement
activ
immun
complex
major
initi
factor
accord
theori
patient
preinfect
immun
singl
dengu
viru
serotyp
make
anamnest
antibodi
respons
infect
second
serotyp
antibodi
nonneutr
yet
crossreact
heterolog
viru
circul
immun
complex
form
may
deposit
blood
vessel
activ
complement
result
shock
syndrom
support
find
dhf
patient
lower
serum
complement
level
circul
immun
complex
deposit
dengu
viru
igm
andlc
globulin
around
blood
vessel
lesion
second
theori
argu
immun
complex
diseas
per
se
propos
instead
nonneutr
antibodi
opson
viru
lead
immunolog
enhanc
viru
infect
mononuclear
phagocyt
possibl
complement
activ
via
altern
pathway
acceler
sever
viral
diseas
would
thu
occur
patient
preinfect
heterotyp
immun
prior
appear
neutral
antibodi
infect
viru
support
view
sever
studi
demonstr
antibodymedi
enhanc
dengu
viru
infect
monkey
cultur
primat
leukocyt
present
studi
show
fip
dhf
antibodymedi
enhanc
diseas
occur
passiv
administ
antibodi
reactiv
fip
viru
neutral
parent
inocul
viru
antibodi
fact
somehow
sensit
recipi
acut
fulmin
diseas
occur
enhanc
infect
fipv
macrophag
seroposit
kitten
may
dengu
viru
infect
reflect
opson
activ
antibodi
nonneutr
reactiv
challeng
viru
present
unclear
whether
nonneutr
fip
antibodi
heterotyp
dhf
homotyp
aleutian
diseas
mink
although
exist
differ
fipv
serotyp
yet
establish
differ
viru
neutral
variou
fipv
isol
crossreact
porcin
coronaviru
suggest
one
fipv
serotyp
may
occur
case
situat
similar
dhf
person
could
develop
seroposit
cat
acut
infect
heterolog
fipv
serotyp
perhap
crossreact
coronaviru
ie
high
titer
nonneutr
crossreact
antibodi
rapid
format
virusantibodi
complex
facilit
viru
replic
persist
mononuclear
phagocyt
widespread
complement
activ
